Matches in Wikidata for { <http://www.wikidata.org/entity/Q58088761> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q58088761 description "article scientifique publié en 2006" @default.
- Q58088761 description "im Jahr 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58088761 description "journal article; published in Acute Cardiac Care in 2006" @default.
- Q58088761 description "journal article; published in Acute Cardiac Care in 2006" @default.
- Q58088761 description "journal article; published in Acute Cardiac Care in 2006" @default.
- Q58088761 description "wetenschappelijk artikel" @default.
- Q58088761 description "наукова стаття, опублікована в січні 2006" @default.
- Q58088761 name "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 name "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 name "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 name "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients" @default.
- Q58088761 type Item @default.
- Q58088761 label "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 label "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 label "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 label "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients" @default.
- Q58088761 prefLabel "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 prefLabel "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 prefLabel "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 prefLabel "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients" @default.
- Q58088761 P1433 Q58088761-2F796EF1-C0CD-464A-ADC5-5D70F6294FD4 @default.
- Q58088761 P1476 Q58088761-6FA1DFB8-A7EB-4178-96BA-7C225BE8B574 @default.
- Q58088761 P2093 Q58088761-96A7F7C2-DBAA-4E37-8B60-1CB217359C66 @default.
- Q58088761 P2093 Q58088761-9E4CB4E1-3CE2-4B49-A2AF-4F5D367D77C9 @default.
- Q58088761 P2860 Q58088761-05A49F2C-E4BD-47BF-BA01-AE84DDD77207 @default.
- Q58088761 P2860 Q58088761-395A1CDD-074E-4ED7-874E-ED1553556166 @default.
- Q58088761 P2860 Q58088761-4C8C23C1-8D93-46DB-9558-A084C1F4C0F9 @default.
- Q58088761 P2860 Q58088761-5550E9A8-E793-4F3D-9AB5-89BA4B93C827 @default.
- Q58088761 P2860 Q58088761-574BE9C6-32BF-4ADD-AC49-DF34A7760D13 @default.
- Q58088761 P2860 Q58088761-5ACFD434-E192-4AAE-A9BC-CF6BD50A1931 @default.
- Q58088761 P2860 Q58088761-60D3233F-AE96-4C41-8718-A8C506D25B39 @default.
- Q58088761 P2860 Q58088761-6F69B54D-C545-4A0E-9F49-5032A24820BD @default.
- Q58088761 P2860 Q58088761-98AFC6F2-6529-4926-86FF-1DD9D4EEF4FD @default.
- Q58088761 P2860 Q58088761-BC6FA7E7-6E9D-403C-9BA5-BC61307404E6 @default.
- Q58088761 P2860 Q58088761-C65A121D-8DFE-479D-A580-6DB056F48C6D @default.
- Q58088761 P2860 Q58088761-D8E450E0-6C98-4AA0-8727-EAB367063CA0 @default.
- Q58088761 P2860 Q58088761-DB02E250-74F2-4B3F-AAF6-B6FB762BD2DA @default.
- Q58088761 P2860 Q58088761-DC5E6144-0589-4F30-A579-3589DD4B7CDF @default.
- Q58088761 P2860 Q58088761-E28C06F0-B8F6-49E9-8CFF-024EF4D91E83 @default.
- Q58088761 P2860 Q58088761-F08CB027-2CB8-47FA-827D-0FEE639F235A @default.
- Q58088761 P304 Q58088761-86BA75DA-DA62-4DB8-96EA-A5A1ACD3D54C @default.
- Q58088761 P31 Q58088761-BDD3535E-BE39-4BE5-AC2C-0B73E17CCE47 @default.
- Q58088761 P356 Q58088761-A59773AD-AD5D-4CA5-A106-4DC714F8C19F @default.
- Q58088761 P433 Q58088761-C269374B-1B15-4441-B42D-1F26892E8636 @default.
- Q58088761 P478 Q58088761-0490AC45-A476-4C3C-ADBA-4CD7A730D96E @default.
- Q58088761 P50 Q58088761-93FC4172-B20D-41C3-A246-1830D4861533 @default.
- Q58088761 P577 Q58088761-2385DD03-5177-4190-9BA9-37AFCB67FCF5 @default.
- Q58088761 P698 Q58088761-22CE3A2F-E701-4321-99DF-6624C7F586E0 @default.
- Q58088761 P856 Q58088761-8CF5F85F-2BA3-48BF-A803-AF17B0EFA989 @default.
- Q58088761 P356 14628840600648200 @default.
- Q58088761 P698 16885070 @default.
- Q58088761 P1433 Q15745553 @default.
- Q58088761 P1476 "Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial)" @default.
- Q58088761 P2093 "Maria Sejersten" @default.
- Q58088761 P2093 "Peter Clemmensen" @default.
- Q58088761 P2860 Q28185728 @default.
- Q58088761 P2860 Q28196902 @default.
- Q58088761 P2860 Q33610405 @default.
- Q58088761 P2860 Q41118717 @default.
- Q58088761 P2860 Q43488488 @default.
- Q58088761 P2860 Q43724527 @default.
- Q58088761 P2860 Q44550270 @default.
- Q58088761 P2860 Q47224336 @default.
- Q58088761 P2860 Q47336586 @default.
- Q58088761 P2860 Q47811192 @default.
- Q58088761 P2860 Q51574013 @default.
- Q58088761 P2860 Q51788004 @default.
- Q58088761 P2860 Q53016257 @default.
- Q58088761 P2860 Q55067861 @default.
- Q58088761 P2860 Q56944438 @default.
- Q58088761 P2860 Q57764006 @default.
- Q58088761 P304 "75-82" @default.
- Q58088761 P31 Q13442814 @default.
- Q58088761 P356 "10.1080/14628840600648200" @default.
- Q58088761 P433 "2" @default.
- Q58088761 P478 "8" @default.
- Q58088761 P50 Q41709790 @default.
- Q58088761 P577 "2006-01-01T00:00:00Z" @default.
- Q58088761 P698 "16885070" @default.
- Q58088761 P856 14628840600648200 @default.